z-logo
Premium
Calcium supplementation, cardiovascular disease and mortality in older women
Author(s) -
Shah Sunil M.,
Carey Iain M.,
Harris Tess,
DeWilde Stephen,
Cook Derek G.
Publication year - 2010
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.1859
Subject(s) - medicine , stroke (engine) , hazard ratio , myocardial infarction , calcium supplementation , cohort study , observational study , vitamin d and neurology , cohort , disease , cause of death , heart failure , confidence interval , mechanical engineering , engineering
Purpose To investigate the long‐term cumulative effect of calcium and vitamin D supplementation on cardiovascular outcomes and death in older women. Methods We undertook an observational cohort study using UK electronic primary care records in the Doctor's Independent Network (DIN‐LINK) database; 9910 women aged 60–89 who started calcium and vitamin D supplementation between 2000 and 2005, with no heart disease or stroke history and who survived disease free for 2 years after supplement initiation were studied. The main outcome was first occurrence of myocardial infarction (MI), stroke or death more than 2 years after initiation. Results In the period from 2 years after supplement initiation, women who had received >600 days supplementation in these first 2 years were no more at risk of MI, stroke or death (hazard ratio 0.82 (0.67–1.01)) compared to women who received ≤90 days supplementation in the first 2 years. Outcomes in the first 2 years were analysed separately and showed similar baseline risks in our comparison groups. Conclusion Two years after initiation, women who have consistently received supplementation with calcium and vitamin D do not experience more cardiovascular events or deaths than women who received minimal supplementation. Copyright © 2009 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom